Clinical Trial: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: B-cell Malignancy
Study Type: INTERVENTIONAL
Official Title: A Phase 1b Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Brief Summary:
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ?2 lines of systemic therapy.
Read more